We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+10.41%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$435B
AUM Growth
+$29.7B
Cap. Flow
-$2.24B
Cap. Flow %
-0.51%
Top 10 Hldgs %
21.82%
Holding
4,210
New
266
Increased
1,586
Reduced
2,101
Closed
160

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$650M
2
AAPL icon
Apple
AAPL
+$468M
3
MRVL icon
Marvell Technology
MRVL
+$458M
4
CVX icon
Chevron
CVX
+$410M
5
WIX icon
WIX.com
WIX
+$392M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$836M
2
BE icon
Bloom Energy
BE
+$727M
3
ACN icon
Accenture
ACN
+$563M
4
AVGO icon
Broadcom
AVGO
+$549M
5
LRCX icon
Lam Research
LRCX
+$543M

Sector Composition

Rank Sector Weight
1 Technology 25.76%
2 Financials 11.48%
3 Industrials 8.17%
4 Healthcare 7.37%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMTI icon
4101
Rockwell Medical
RMTI
$27.6M
-14,830
Closed -$126K
RUM icon
4102
CALL
RUM Group Inc
RUM
$1.66B
-53,500
Closed -$480K
RYAM icon
4103
Rayonier Advanced Materials
RYAM
$591M
-105,703
Closed -$407K
SAGE
4104
DELISTED
Sage Therapeutics
SAGE
-169,860
Closed -$1.55M
SCS
4105
DELISTED
Steelcase
SCS
-602,739
Closed -$6.29M
SIBN icon
4106
SI-BONE Inc
SIBN
$795M
-51,924
Closed -$977K
SKX
4107
DELISTED
Skechers
SKX
-296,965
Closed -$18.7M
SNAL icon
4108
Snail Inc
SNAL
$44.7M
-2,920
Closed -$20K
SPRY icon
4109
ARS Pharmaceuticals
SPRY
$563M
-345,055
Closed -$6.02M
SPTN
4110
DELISTED
SpartanNash
SPTN
-76,540
Closed -$2.03M
QVMT
4111
Invesco S&P 500 Concentrated QVM ETF
QVMT
$130M
-16,160
Closed -$841K
STR
4112
DELISTED
Sitio Royalties
STR
-24,751
Closed -$455K
SWIM icon
4113
Latham Group
SWIM
$673M
-28,136
Closed -$180K
SWTX
4114
DELISTED
SpringWorks Therapeutics
SWTX
-7,131
Closed -$335K
TDUP icon
4115
ThredUp
TDUP
$760M
-92,603
Closed -$694K
TGI
4116
DELISTED
Triumph Group
TGI
-169,513
Closed -$4.36M
TROX icon
4117
Tronox
TROX
$981M
-1,223,259
Closed -$6.2M
TRVI icon
4118
Trevi Therapeutics
TRVI
$2.62B
-154,854
Closed -$847K
TTGT icon
4119
TechTarget
TTGT
$323M
-51,169
Closed -$398K
TVTX icon
4120
Travere Therapeutics
TVTX
$5.2B
-73,661
Closed -$1.09M
TZOO icon
4121
Travelzoo
TZOO
$77.8M
-24,618
Closed -$313K
VERV
4122
DELISTED
Verve Therapeutics
VERV
-103,955
Closed -$1.17M
VST icon
4123
CALL
Vistra
VST
$50.1B
-13,400
Closed -$2.6M
VTYX
4124
DELISTED
Ventyx Biosciences
VTYX
-28,031
Closed -$60K
WBA
4125
DELISTED
Walgreens Boots Alliance
WBA
-385,077
Closed -$4.42M

Similar funds

Ameriprise's Q3 2025 Portfolio in Review

As of Q3 2025, Ameriprise held 4,210 positions worth $435B, up 7.3% from $406B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Ameriprise's Q3 2025 filing shows 266 new, 1,586 increased, 2,101 reduced and 160 closed positions. Its largest new stake was Aptiv: 3,450,314 shares worth $298M. The largest sale was Microsoft, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.

  • Ameriprise's largest Q3 2025 buy was Aptiv: 3,450,314 shares worth $298M.
  • Ameriprise added most to Applied Materials in Q3 2025, an estimated $650M increase.
  • Ameriprise's biggest Q3 2025 reduction was Microsoft, cutting an estimated $836M.
  • Ameriprise fully exited Hess in Q3 2025, selling an estimated $77.2M.
  • Ameriprise's ten largest holdings make up 22% of its $435B portfolio in Q3 2025.
  • Ameriprise opened 266 new positions and closed 160 in Q3 2025.
  • Ameriprise's portfolio value rose 7.3% quarter-over-quarter to $435B.

Based on Ameriprise's 13F filing for Q3 2025, filed 14 Nov 2025.